⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

February 1, 2026Pathology

From thymus to bone marrow: a case report highlighting thymoma-associated bone marrow dysfunction

Ashlee Hedrick Sasanka M. Handunnetti Rakin Chowdhury

View Full Paper

Ask AI

Bookmark

Share

Key Points

To examine the relationship between thymoma and bone marrow dysfunction, particularly in patients with pure red cell aplasia and Good’s syndrome.
Case report analysis of a patient with thymoma-related bone marrow dysfunction.
Assessment of immune dysregulation and associated conditions, including pure red cell aplasia and Good’s syndrome.
The patient exhibited both pure red cell aplasia and Good’s syndrome, illustrating the complexity of thymoma-related immune conditions.
Findings suggest a significant association between thymoma, PRCA, and immune dysregulation.

Implication

Case report reveals thymoma's role in bone marrow dysfunction and immune dysregulation, highlighting rare cases of PRCA and Good’s syndrome.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Hedrick et al. (2026) studied this question.

synapsesocial.com/papers/699a534bfdaf4e3c1268eea7 https://doi.org/10.1016/j.pathol.2026.01.261

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Pure Red Cell Aplasia as an Isolated Paraneoplastic Manifestation of Thymoma: A Case Report and Literature ReviewCase Report · 2026
2Pure Red Cell Aplasia Associated With Thymic Tumors, a Nationwide Retrospective Study2025 · 5 citations
3Pure Red Cell Aplasia That Developed 13 Years After Thymoma Treatment: A Case Report and Literature Review2025 · 1 citations
4Good’s Syndrome With Pure Red Cell Aplasia and Subclinical Myasthenia Gravis: A Case Report and Review of Literature2024 · 1 citations
5Pure red cell aplasia associated with thymic follicular lymphoid hyperplasia: Complete remission after thymectomy without immunosuppression2025